Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicineJosephine A. Taverna, Chun‐Liang Chen, Daniel T. DeArmond et al.|Lung Cancer|2024Cited by 21
Correlation Revealed between Gemtuzumab-Ozogamicin Efficacy and CD33+ Expression in AML Primary Samples through a Novel AML in Vitro ModelMara Gilardi, Michael Ritchie, Garima Kaushik et al.|Blood|2023Cited by 1
<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized MedicineChia‐Nung Hung, Josephine A. Taverna, Paweł A. Osmulski et al.|Preprints.org|2023Cited by 0